BlackRock »

Day One Biopharmaceuticals I shares owned by BlackRock

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by BlackRock

Quarter filed Position value Share count Share price at filing
2024-12-31 $78M 6.2M 12.67
2024-09-30 $66M 4.7M 13.93

More positions owned by BlackRock

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Mastercard Incorporated Cl A (MA)

View all positions for BlackRock

Top funds holding Day One Biopharmaceuticals I

FMR
Atlas Venture Life Science Advisors
BlackRock
Vanguard Group
RA Capital Management
Braidwell
Franklin Resources
Fairmount Funds Management
State Street Corporation
Pictet Asset Management Holding SA
Estuary Capital Management
Deerfield Management Company
Alyeska Investment Group
Vestal Point Capital
TimesSquare Capital Management

View all funds holding Day One Biopharmaceuticals I